Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Preferential retroviral-mediated transduction of EBV- and CMV-specific T cells after polyclonal T-cell activation

Abstract

Graft-versus-host disease, resulting from the T cells present in allogeneic hematopoietic stem cell (HSC) inoculums, can potentially be treated if a suicide gene has been introduced into the donor T cells. However, the diversity and functionality of the transfused T-cell population, including EBV- (EBV-T) and CMV-specific (CMV-T) CD8+ T cells, which are particularly important for immunosuppressed individuals undergoing HSC transplants, are often modified by the gene transfer protocol. Here, we show that following polyclonal T-cell activation, EBV-T and CMV-T cells are preferentially transduced by oncoretroviral vectors, as compared to the bulk CD8+ T-cell population. This preferential transduction is associated with higher surface levels of PiT-2, the receptor for the amphotropic envelope with which the virions are pseudotyped. Moreover, EBV-T and CMV-T cells proliferate more extensively as compared to bulk CD8+ T cells. Thus, retroviral-mediated transduction can be biased toward a given antigenic specificity, even under conditions of polyclonal stimulation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Tiberghien P et al. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 1994; 84: 1333–1341.

    CAS  PubMed  Google Scholar 

  2. Bonini C et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 1997; 276: 1719–1724.

    Article  CAS  PubMed  Google Scholar 

  3. Tiberghien P et al. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood 2001; 97: 63–72.

    Article  CAS  PubMed  Google Scholar 

  4. Robinet E et al. A closed culture system for the ex vivo transduction and expansion of human T lymphocytes. J Hematother 1998; 7: 205–215.

    Article  CAS  PubMed  Google Scholar 

  5. Sauce D et al. Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein–Barr virus potential through both culture-dependent and selection process-dependent mechanisms. Blood 2002; 99: 1165–1173.

    Article  CAS  PubMed  Google Scholar 

  6. Sauce D et al. Retrovirus-mediated gene transfer in polyclonal T cells results in lower apoptosis and enhanced ex vivo cell expansion of CMV-reactive CD8T cells as compared to EBV-reactive CD8T cells. Blood 2003; 102: 1241–1248.

    Article  CAS  PubMed  Google Scholar 

  7. Contassot E et al. Retrovirus-mediated transfer of the herpes simplex type I thymidine kinase gene in alloreactive T lymphocytes. Hum Gene Ther 1998; 9: 73–80.

    Article  CAS  PubMed  Google Scholar 

  8. Miller DG, Adam MA, Miller AD . Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239–4242.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Koehne G, Gallardo HF, Sadelain M, O’Reilly RJ . Rapid selection of antigen-specific T lymphocytes by retroviral transduction. Blood 2000; 96: 109–117.

    CAS  PubMed  Google Scholar 

  10. Garin MI et al. Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene. Blood 2001; 97: 122–129.

    Article  CAS  PubMed  Google Scholar 

  11. Kavanaugh MP et al. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 1994; 91: 7071–7075.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Bodinier M et al. Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding. Nat Med 2000; 6: 707–710.

    Article  CAS  PubMed  Google Scholar 

  13. Romero P et al. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J Exp Med 1998; 188: 1641–1650.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Sauce D, el al . Influence of ex vivo expansion and retrovirus-mediated gene transfer on primary T lymphocyte phenotype and functions. J Hematother 2002; 11: 929–940.

    Article  CAS  Google Scholar 

  15. Manel N et al. The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesis. Blood 2003; 101: 1913–1918.

    Article  CAS  PubMed  Google Scholar 

  16. Wells AD et al. Following the fate of individual T cells throughout activation and clonal expansion. J Clin Invest 1997; 100: 3173–3183.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Chien ML, Foster JL, Douglas JL, Garcia JV . The amphotropic murine leukemia virus receptor gene encodes a 71-kilodalton protein that is induced by phosphate depletion. J Virol 1997; 71: 4564–4570.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the Programme Hospitalier de Recherche Clinique (PHRC 2000 #RC39), the Association Française contre la Myopathie and the Ministère de l’Enseignement Supérieur et de la Recherche (Centre Réseau de Développement des Thérapies Géniques (CRTG)), the Association pour la Recherche sur le Cancer (Grants # 4350 & # 7665), the Ligue contre le Cancer, Comité du Doubs and the European Community (Biomed contract # CT97-2074 and QLK3-CT-2001-01265). Patricia Mercier has benefited from a grant from the Ligue Contre le Cancer, Comité du Doubs. We also thank Dr Mark Bonyhadi (Xcyte Therapies Inc., Seattle, WA, USA) for providing us with CD3/CD28 beads.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sauce, D., Mercier, P., Battini, JL. et al. Preferential retroviral-mediated transduction of EBV- and CMV-specific T cells after polyclonal T-cell activation. Gene Ther 11, 1019–1022 (2004). https://doi.org/10.1038/sj.gt.3302273

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302273

Keywords

This article is cited by

Search

Quick links